SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-119121
Filing Date
2023-11-16
Accepted
2023-11-16 16:15:20
Documents
16
Period of Report
2023-11-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330867d1_8k.htm   iXBRL 8-K 30984
2 EXHIBIT 99.1 tm2330867d1_ex99-1.htm EX-99.1 8951
3 EXHIBIT 99.2 tm2330867d1_ex99-2.htm EX-99.2 19625
7 GRAPHIC tm2330867d1_ex99-1img001.jpg GRAPHIC 2066
8 GRAPHIC tm2330867d1_ex99-2img001.jpg GRAPHIC 2837
  Complete submission text file 0001104659-23-119121.txt   250134

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20231116.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20231116_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20231116_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2330867d1_8k_htm.xml XML 3312
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 231414766
SIC: 2834 Pharmaceutical Preparations